![Neovii & Mundipharma Agreement for Solid Organ & Stem Cell Transplant](https://cleanroomconnect.com/wp-content/uploads/2018/07/stem-cell-transplant-1080x675.jpg)
Neovii & Mundipharma Agreement for Solid Organ & Stem Cell Transplant
Neovii pharmaceuticals AG of Rapperswil, Switzerland and Mundipharma have entered into an agreement giving Mundipharma the rights to develop and distribute its polyclonal antibody immunosuppressant Grafalon®, in China and Japan from end October.